Topics covered included recent MTUS updates, the pharmacy fee schedule update, UR and IMR updates, and more.
Topics covered included recent MTUS updates, the pharmacy fee schedule update, UR and IMR updates, and more.
Open to public comment until September 12th, the guideline is intended to establish best practices for diagnosis and treatment.
The meeting covered fee schedule policies impacting physician-dispensed medication, electronic delivery for EOBs, and more.
The next meeting in October will deliver an expanded formulary list, with a review of the top five to ten exempt drugs based on utilization.
The July 16th meeting will review upcoming MTUS changes, which go into effect August 6th.
Fee schedule clarity and defined reimbursement caps were discussed as ways to reduce ambiguity and prevent payment disputes.
The DIR must adopt the ODG formulary by July 1, 2027.
These different bills would prevent AI from denying, delaying, modifying, or making clinical decisions in healthcare.
The meeting will take place on June 12th, aiming to explore current trends, challenges, and proposed solutions related to these drugs.
Topics addressed included changes to the fee schedule, utilization review, spinal therapy guidelines, and more.
Topics discussed include proposals for a fee schedule by 2027, employer direction of care, and allowing more providers to provide disability opinions.
In a DWC meeting, stakeholders spoke regarding the timeline of when a physician evaluates a patient, versus other types of providers.
Healthe attended the April 16th meeting, capturing key updates regarding the pharmacy fee schedule and drug formulary.
Senate Bill 317 originally focused on provider panels, but a recent hearing amended the bill to include a workers’ comp formulary.
The hybrid meeting will cover the pharmacy fee schedule, biosimilars, cannabis coverage, and payments for topical drugs.
